RecruitingNCT06760052

Longitudinal Data Registry of Plasma Cell Dyscrasia

Longitudinal Data Registry of a Spectrum of Plasma Cell Dyscrasia with Long-term Follow-up


Sponsor

Shanghai Zhongshan Hospital

Enrollment

2,000 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to identify clinical characteristics, response and clinical outcome of plasma cell dyscrasia (PCD) diagnosed in Zhongshan Hospital, Fudan University from May 2023. In its current version, the registry incorporates historical data (collected from 2007) and is prospectively collecting follow-up data and recording patient outcomes.


Eligibility

Min Age: 19 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This registry study is collecting long-term data from patients with plasma cell disorders — conditions affecting plasma cells in the bone marrow, including multiple myeloma, MGUS, POEMS syndrome, and AL amyloidosis — to better understand how these diseases progress and respond to treatment over time. **You may be eligible if...** - You have been diagnosed with a plasma cell disorder (such as multiple myeloma, MGUS, POEMS syndrome, or AL amyloidosis) at Zhongshan Hospital between 2007 and 2027 - Your diagnosis, treatment, and follow-up records are complete - You consent to participate **You may NOT be eligible if...** - You are pregnant, breastfeeding, or of childbearing age but refuse to use reliable contraception - You have a severe psychiatric illness - The investigator determines participation is not appropriate for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06760052


Related Trials